Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Aethlon Medical Provides Clinical Update at International Conference on Dialysis
February 20th, 2009
Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chief Science Officer, Dr. Richard H. Tullis presented a clinical report on the Aethlon Hemopurifier® to Nephrologists attending the International Conference on Dialysis on January 29th. The focal point of Dr. Tullis’s presentation was the use of the Hemopurifier® to manage disease progression in end-stage renal disease (ESRD) patients infected with viral pathogens, including Hepatitis-C (HCV) and Human Immunodeficiency Virus (HIV). Aethlon anticipates Nephrologists will become early adopters of the Hemopurifier® as viral infection significantly increases patient mortality in ESRD patients who require regular dialysis...
Source: Health Business Week (2009-02-20)
|
